CITRAMON P

Registration number:ЛСР-005236/09
International non-proprietary name:acetylsalicylic acid + caffeine + paracetamol
Pharmaceutical form:tablets
Pharmacotherapeutic group:Combination analgesic agent (NSAID + nonnarcotic analgesic drug + psychostimulant)
Dosage form:tablets No. 10 and No. 20
Composition:Active substances: acetylsalicylic acid - 240 mg, paracetamol - 180 mg, caffeine - 30 mg

CITRAMON P is a combination drug.
CITRAMON P has an antipyretic, analgesic, and anti-inflammatory action, dilates blood vessels of the brain, heart, kidneys, and decreases somnolence and fatigue.

Acetylsalicylic acid has an antipyretic and anti-inflammatory action, it reduces pain, especially that caused by an inflammatory process, and moderately suppresses platelets aggregation and thrombi formation, improves microcirculation in the inflammation focus.
Paracetamol has an analgesic, antipyretic, and slight anti-inflammatory action, which is associated with its effects on the heat-regulating center in hypothalamus and mildly expressed ability to inhibit prostaglandins (Pg) synthesis within peripheral tissues.
Caffeine increases the spinal cord reflex excitability, activates the inspiratory and vasomotor centers, dilates blood vessels of skeletal muscles, brain, heart, kidneys, reduces platelets aggregation; decreases somnolence, fatigue.
Within such combination, low doses of caffeine do not have stimulating action with respect to central nervous system, but it contributes to regulation of the cerebral vessels tonicity.

Indications

Mild to moderate pain syndrome of various origin:

— headache;
— migraine;
— toothache;
— neuralgia,
— myalgia;
— arthralgia;
— algodysmenorrhea.
Fever syndrome:

in acute respiratory diseases, including influenza.

Method of administration and posology: